These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 1761362)

  • 41. Difference in T helper responses during hepatitis flares in hepatitis B e antigen (HBeAg)-positive patients with genotypes B and C: implication for early HBeAg seroconversion.
    Yuen MF; Wong DK; Zheng BJ; Chan CC; Yuen JC; Wong BC; Lai CL
    J Viral Hepat; 2007 Apr; 14(4):269-75. PubMed ID: 17381719
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of an anti-tumor polysaccharide, schizophyllan, on interferon-gamma and interleukin 2 production by peripheral blood mononuclear cells.
    Sakagami Y; Mizoguchi Y; Shin T; Seki S; Kobayashi K; Morisawa S; Yamamoto S
    Biochem Biophys Res Commun; 1988 Sep; 155(2):650-5. PubMed ID: 2971353
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The antiviral compound ribavirin modulates the T helper (Th) 1/Th2 subset balance in hepatitis B and C virus-specific immune responses.
    Hultgren C; Milich DR; Weiland O; Sällberg M
    J Gen Virol; 1998 Oct; 79 ( Pt 10)():2381-91. PubMed ID: 9780043
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Kinetics of hepatitis B surface antigen-specific immune responses in acute and chronic hepatitis B or after HBs vaccination: stimulation of the in vitro antibody response by interferon gamma.
    Böcher WO; Herzog-Hauff S; Schlaak J; Meyer zum Büschenfeld KH; Löhr HF
    Hepatology; 1999 Jan; 29(1):238-44. PubMed ID: 9862872
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hepatitis with isolated serum antibody to hepatitis B core antigen. A variant of non-A, non-B hepatitis?
    Lai KN; Lai FM; Leung NW; Lo ST; Tam JS
    Am J Clin Pathol; 1990 Jan; 93(1):79-83. PubMed ID: 2104740
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Core promoter mutations of hepatitis B virus for the response to interferon in e antigen-positive chronic hepatitis B.
    Kanai K; Kako M; Aikawa T; Hino K; Tsubouchi H; Takehira Y; Iwabuchi S; Kawasaki T; Tsuda F; Okamoto H; Miyakawa Y; Mayumi M
    Am J Gastroenterol; 1996 Oct; 91(10):2150-6. PubMed ID: 8855739
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A randomized controlled trial of thymosin-alpha1 versus interferon alfa treatment in patients with hepatitis B e antigen antibody--and hepatitis B virus DNA--positive chronic hepatitis B.
    Andreone P; Cursaro C; Gramenzi A; Zavagliz C; Rezakovic I; Altomare E; Severini R; Franzone JS; Albano O; Ideo G; Bernardi M; Gasbarrini G
    Hepatology; 1996 Oct; 24(4):774-7. PubMed ID: 8855175
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hepatitis B virus core and e antigen: immune recognition and use as a vaccine carrier moiety.
    Schödel F; Peterson D; Milich D
    Intervirology; 1996; 39(1-2):104-10. PubMed ID: 8957676
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Peginterferon-α does not improve early peripheral blood HBV-specific T-cell responses in HBeAg-negative chronic hepatitis.
    Penna A; Laccabue D; Libri I; Giuberti T; Schivazappa S; Alfieri A; Mori C; Canetti D; Lampertico P; Viganò M; Colombo M; Loggi E; Missale G; Ferrari C
    J Hepatol; 2012 Jun; 56(6):1239-46. PubMed ID: 22326467
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Relative functional affinity of specific anti-core IgG in different categories of hepatitis B virus infection.
    Thomas HI
    J Med Virol; 1997 Mar; 51(3):189-97. PubMed ID: 9139082
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of alpha-interferon on gamma-interferon production of peripheral blood mononuclear cells in hepatitis B virus carriers.
    Katayama K; Hayashi N; Takehara T; Towata T; Kasahara A; Fusamoto H; Kamada T
    J Clin Immunol; 1992 Sep; 12(5):347-52. PubMed ID: 1430105
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The secreted hepatitis B precore antigen can modulate the immune response to the nucleocapsid: a mechanism for persistence.
    Milich DR; Chen MK; Hughes JL; Jones JE
    J Immunol; 1998 Feb; 160(4):2013-21. PubMed ID: 9469465
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Quantitative assessment of IgM antibodies towards an immunodominant B-cell epitope within the preS2 domain of HBV in the natural course and during combined prednisone/interferon alpha 2b treatment of chronic hepatitis B virus infection.
    Fei GZ; Sylvan SP; Hellström UB; Yao GB
    J Med Virol; 1995 Jun; 46(2):138-43. PubMed ID: 7636501
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immunohistological study of intrahepatic expression of hepatitis B core and E antigens in chronic type B hepatitis.
    Chu CM; Liaw YF
    J Clin Pathol; 1992 Sep; 45(9):791-5. PubMed ID: 1401209
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The delivery of HBcAg via Tat-PTD enhances specific immune response and inhibits Hepatitis B virus replication in transgenic mice.
    Chen X; Lai J; Pan Q; Tang Z; Yu Y; Zang G
    Vaccine; 2010 May; 28(23):3913-9. PubMed ID: 20394723
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hepatitis B virus variants with core gene deletions in the evolution of chronic hepatitis B infection.
    Marinos G; Torre F; Günther S; Thomas MG; Will H; Williams R; Naoumov NV
    Gastroenterology; 1996 Jul; 111(1):183-92. PubMed ID: 8698197
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Humoral and cellular immune responses to hepatitis B vaccination in hepatitis B surface antigen-carrier children who cleared serum-hepatitis B surface antigen.
    Hsu HY; Chang MH; Hsieh RP; Ni YH; Chi WK
    Hepatology; 1996 Dec; 24(6):1355-60. PubMed ID: 8938161
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hepatitis B infection and changes in interferon-alpha and -gamma production in patients with systemic lupus erythematosus in Taiwan.
    Lu CL; Tsai ST; Chan CY; Hwang SJ; Tsai CY; Wu JC; Lu RH; Lin BC; Lee SD
    J Gastroenterol Hepatol; 1997 Apr; 12(4):272-6. PubMed ID: 9195365
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Regulation of the neutralizing anti-hepatitis B surface (HBs) antibody response in vitro in HBs vaccine recipients and patients with acute or chronic hepatitis B virus (HBV) infection.
    Böcher WO; Herzog-Hauff S; Herr W; Heermann K; Gerken G; Meyer Zum Büschenfelde KH; Löhr HF
    Clin Exp Immunol; 1996 Jul; 105(1):52-8. PubMed ID: 8697635
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hepatitis B virus antigen-specific T-cell activation in patients with acute and chronic hepatitis B.
    Jung MC; Spengler U; Schraut W; Hoffmann R; Zachoval R; Eisenburg J; Eichenlaub D; Riethmüller G; Paumgartner G; Ziegler-Heitbrock HW
    J Hepatol; 1991 Nov; 13(3):310-7. PubMed ID: 1808224
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.